| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
AO1: IMPACT OF POST-FRACTURE TREATMENT COSTS AND MODEL TIME HORIZON ON COST-EFFECTIVENESS OF OSTEOPOROSIS THERAPIES
|
Grima, DT
|
|
2000
|
3 |
Supplement 1 |
p. 300-
1 p.
|
artikel
|
| 2 |
A 1-Year Cost-Effectiveness Model for the Treatment of Chronic Schizophrenia with Acute Exacerbations in Belgium
|
Lecomte, Pascal
|
|
2000
|
3 |
Supplement 1 |
p. 1-11
11 p.
|
artikel
|
| 3 |
CEB6: THE IMPORTANCE OF COMPARABLE PATIENT POPULATIONS IN COST-EFFECTIVENESS ANALYSES: TOLTERODINE VERSUS OXYBUTININ XL FOR TREATING OVERACTIVE BLADDER
|
Schonfeld, WH
|
|
2000
|
3 |
Supplement 1 |
p. 66-
1 p.
|
artikel
|
| 4 |
Clinical and Economic Outcomes of Coronary Angioplasty Alone or in Combination with Stents in Academic Health Centers: A Retrospective Database Analysis
|
Oinonen, Michael J.
|
|
2000
|
3 |
Supplement 1 |
p. 253-260
8 p.
|
artikel
|
| 5 |
CV4: THE INFLUENCE OF NON-CARDIAC VASCULAR DISEASE ON THE COST-EFFECTIVENESS OF SCREENING FOR LEFT VENTRICULAR SYSTOLIC DYSFUNCTION (LVSD)
|
Davey, PC
|
|
2000
|
3 |
Supplement 1 |
p. 298-299
2 p.
|
artikel
|
| 6 |
DH4: SCHIZOPHRENIA CARE AND ASSESSMENT PROGRAM (SCAP): IMPACT OF CLINICAL AND FUNCTIONAL STATUS AND TYPE OF MEDICATION TREATMENT ON OUTPATIENT PSYCHIATRIC UTILIZATION
|
Russo, P
|
|
2000
|
3 |
Supplement 1 |
p. 53-
1 p.
|
artikel
|
| 7 |
DUC1: DRUG UTILIZATION OF CISAPRIDE AND CONTRAINDICATED DRUGS IN A US MANAGED CARE POPULATION
|
Guo, JJ
|
|
2000
|
3 |
Supplement 1 |
p. 59-60
2 p.
|
artikel
|
| 8 |
Economic Evaluation of Enoxaparin vs. Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients
|
Pechevis, Marc
|
|
2000
|
3 |
Supplement 1 |
p. 389-396
8 p.
|
artikel
|
| 9 |
GU3: ERADICATION OF HELICOBACTER PYLORI TO PREVENT PEPTIC ULCERS PRIOR TO NSAID THERAPY-A COST-EFFECTIVENESS ANALYSIS
|
You, JHS
|
|
2000
|
3 |
Supplement 1 |
p. 305-306
2 p.
|
artikel
|
| 10 |
PAO2: A COST-COST STUDY COMPARING ETANERCEPT WITH INFLIXIMAB IN MODERATE TO SEVERE RHEUMATOID ARTHRITIS
|
Nuijten, MJC
|
|
2000
|
3 |
Supplement 1 |
p. 334-
1 p.
|
artikel
|
| 11 |
PCD15: HOW MEANINGFUL ARE THE CORONARY BENEFITS OF SELECTIVE ESTROGEN RECEPTOR MODULATORS?
|
Russell, MW
|
|
2000
|
3 |
Supplement 1 |
p. 72-
1 p.
|
artikel
|
| 12 |
PCD12: SPIRONOLACTONE IN HEART FAILURE: LIFE AND COST SAVING TREATMENT IN POLAND
|
Kuzniar, J
|
|
2000
|
3 |
Supplement 1 |
p. 71-
1 p.
|
artikel
|
| 13 |
PCH4: APPLICATION OF PHARMACOECONOMICS AND OUTCOMES RESEARCH ON DECISION-MAKING PATTERNS BY MEDICAL ONCOLOGISTS
|
Sarpong, DF
|
|
2000
|
3 |
Supplement 1 |
p. 129-130
2 p.
|
artikel
|
| 14 |
PCN9: AN APPROACH TO DESIGNING A MULTINATIONAL MODEL FOR THE CURRENT TREATMENT OF BREAST CANCER
|
Noe, LN
|
|
2000
|
3 |
Supplement 1 |
p. 353-
1 p.
|
artikel
|
| 15 |
PCV22: COST-EFFECTIVENESS OF HMG-CoA REDUCTASE INHIBITORS AND FIBRATES THERAPY IN ELDERLY WOMEN WITH CORONARY ARTERY DISEASE
|
Lazebnik, LB
|
|
2000
|
3 |
Supplement 1 |
p. 318-
1 p.
|
artikel
|
| 16 |
PCV5: ECONOMIC EVALUATION OF RAMIPRIL IN THE TREATMENT OF PATIENTS AT HIGH RISK OF CARDIOVASCULAR EVENTS
|
Backhouse, ME
|
|
2000
|
3 |
Supplement 1 |
p. 311-
1 p.
|
artikel
|
| 17 |
PCV8: HOSPITALIZATION COSTS AFTER FIRST ACUTE CORONARY SYNDROME: A COMBINED MODEL APPROACH
|
Wang, J
|
|
2000
|
3 |
Supplement 1 |
p. 312-
1 p.
|
artikel
|
| 18 |
PDB4: COST-EFFECTIVENESS OF DIABETIC FOOT ULCER TREATMENT WITH AUTOLOGOUS PLATELET RELEASATE
|
Kantor, J
|
|
2000
|
3 |
Supplement 1 |
p. 136-
1 p.
|
artikel
|
| 19 |
PDB1: RESOURCE USE AND COST ASSOCIATED WITH MICRO- AND MACROVASCULAR COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES
|
Goertz, A
|
|
2000
|
3 |
Supplement 1 |
p. 135-
1 p.
|
artikel
|
| 20 |
PDH1: ECONOMIC IMPLICATIONS FOR SAFETY-NET HOSPITALS: SCREENING FOR HEPATITIS C
|
Singer, ME
|
|
2000
|
3 |
Supplement 1 |
p. 153-
1 p.
|
artikel
|
| 21 |
PDH29: FACTORS AFFECTING ASTHMATIC, DIABETIC, AND HYPERTENSIVE PATIENT SELF-REPORTED COMPLIANCE IN A PHARMACEUTICAL CARE DEMONSTRATION PROJECT
|
Chaikledkaew, U
|
|
2000
|
3 |
Supplement 1 |
p. 164-
1 p.
|
artikel
|
| 22 |
PGS2: PHARMACOECONOMIC MODELING IN ASSISTED REPRODUCTION TECHNOLOGIES: RECOMBINANT FSH VERSUS URINARY FSH
|
Auray, JP
|
|
2000
|
3 |
Supplement 1 |
p. 341-
1 p.
|
artikel
|
| 23 |
PGU8: ANALYSIS OF THE DIRECT COST GENERATED BY INFLIXIMAB TO NORMALIZE QUALITY OF LIFE IN PATIENTS WITH CROHN'S DISEASE
|
Annemans, L
|
|
2000
|
3 |
Supplement 1 |
p. 359-
1 p.
|
artikel
|
| 24 |
PGU11: DEVELOPMENT AND PRELIMINARY PSYCHOMETRIC VALIDATION OF THE PATIENT ASSESSMENT OF UPPER GASTROINTESTINAL DISORDERS-SYMPTOM SEVERITY INDEX (PAGI-SYM) IN GASTROPARESIS
|
Schmier, J
|
|
2000
|
3 |
Supplement 1 |
p. 360-
1 p.
|
artikel
|
| 25 |
PHDE4: PHARMACOECONOMIC EVALUATION OF CALCIPOTRIOL AND UVB IN THE TREATMENT OF PSORIASIS IN THE NETHERLANDS
|
de Rie, MA
|
|
2000
|
3 |
Supplement 1 |
p. 376-
1 p.
|
artikel
|
| 26 |
PHV15: CLINICAL AND ECONOMIC BENEFITS OF THE PNEUMOCOCCAL CONJUGATE VACCINE IN CHILDREN
|
Oster, G
|
|
2000
|
3 |
Supplement 1 |
p. 122-
1 p.
|
artikel
|
| 27 |
PHV5: EFFECTIVENESS AND COSTS OF ANTIBIOTICS IN THE AMBULATORY TREATMENT OF RESPIRATORY TRACT INFECTIONS
|
Laurier, C
|
|
2000
|
3 |
Supplement 1 |
p. 118-
1 p.
|
artikel
|
| 28 |
PHV18: SAFETY-NET HOSPITAL PERSPECTIVE: COST-EFFECTIVENESS OF TREATMENT FOR HEPATITIS C
|
Singer, ME
|
|
2000
|
3 |
Supplement 1 |
p. 123-
1 p.
|
artikel
|
| 29 |
PID10: COST-EFFECTIVENESS ANALYSIS OF ANTIBIOTIC PROPHYLAXIS IN INTRA-ABDOMINAL SURGERY
|
Rozenson, O
|
|
2000
|
3 |
Supplement 1 |
p. 324-325
2 p.
|
artikel
|
| 30 |
PID7: MULTITHERAPIES: TOWARDS COST-SAVING STRATEGIES IN REAL LIFE?
|
Le Pen, C
|
|
2000
|
3 |
Supplement 1 |
p. 323-324
2 p.
|
artikel
|
| 31 |
PMDE1: SOCIETAL IMPACT OF LOST EARNINGS ASSOCIATED WITH AGE-RELATED MACULOPATHY
|
Hua, K
|
|
2000
|
3 |
Supplement 1 |
p. 374-375
2 p.
|
artikel
|
| 32 |
PMDH5: TEMPORAL TRENDS AND ETHNIC VARIATIONS IN AMENABLE MORTALITY IN SINGAPORE FROM 1965 TO 1994: THE IMPACT OF HEALTH CARE IN TRANSITION
|
Niti, M
|
|
2000
|
3 |
Supplement 1 |
p. 369-370
2 p.
|
artikel
|
| 33 |
PMH3: ALZHEIMER'S DISEASE COST OF CARE IN MANAGED CARE
|
Richards, KM
|
|
2000
|
3 |
Supplement 1 |
p. 78-
1 p.
|
artikel
|
| 34 |
PMH12: DATA TRIANGULATION IN THE ASSESSMENT OF SUBSTANCE ABUSE TREATMENT OUTCOMES IN ADOLESCENT POPULATIONS
|
Ciesla, J
|
|
2000
|
3 |
Supplement 1 |
p. 347-348
2 p.
|
artikel
|
| 35 |
PMH8: PHARMACOECONOMIC MODELLING IN DEPRESSION: AID OR TRAP
|
Toumi, M
|
|
2000
|
3 |
Supplement 1 |
p. 346-
1 p.
|
artikel
|
| 36 |
PMH28: QUALITY OF LIFE DIFFERENCES BETWEEN PATIENTS WITH EPISODIC AND TRANSFORMED MIGRAINE
|
Meletiche, DM
|
|
2000
|
3 |
Supplement 1 |
p. 87-88
2 p.
|
artikel
|
| 37 |
PMH31: TREATMENT OF CHILDHOOD DEPRESSION IN A MANAGED CARE POPULATION
|
McLaughlin, T
|
|
2000
|
3 |
Supplement 1 |
p. 88-89
2 p.
|
artikel
|
| 38 |
PMH14: USE OF OLANZAPINE AND RISPERIDONE AT BASELINE IN A PROSPECTIVE STUDY OF THE COURSE OF TREATMENT FOR SCHIZOPHRENIA
|
Johnstone, BM
|
|
2000
|
3 |
Supplement 1 |
p. 82-
1 p.
|
artikel
|
| 39 |
PMT34: ASSESSING PHYSICIAN PRACTICE PROFITABILITY USING AN ACTIVITY BASED COSTING MODEL
|
Stephens, JM
|
|
2000
|
3 |
Supplement 1 |
p. 113-
1 p.
|
artikel
|
| 40 |
PMT16: ESTIMATION OF ANNUAL CARDIOVASCULAR RISK IN PILOTS
|
Milne, RJ
|
|
2000
|
3 |
Supplement 1 |
p. 106-107
2 p.
|
artikel
|
| 41 |
PMT2: RELIABILITY OF PRESCRIPTION CLAIMS DATA FOR HEALTH CARE RESEARCH
|
Thomas, J
|
|
2000
|
3 |
Supplement 1 |
p. 101-
1 p.
|
artikel
|
| 42 |
PMW5: A PHARMACOECONOMIC EVALUATION OF HORMONE REPLACEMENT THERAPY IN THE UNITED KINGDOM AND BELGIUM
|
Doyle, JJ
|
|
2000
|
3 |
Supplement 1 |
p. 100-
1 p.
|
artikel
|
| 43 |
PNR7: COST-EFFECTIVENESS ANALYSIS OF ENTACAPONE IN ADVANCED PARKINSON'S DISEASE A MARKOV PROCESS ANALYSIS
|
Nuijten, MJC
|
|
2000
|
3 |
Supplement 1 |
p. 365-
1 p.
|
artikel
|
| 44 |
POS3: THE SIMPLE CALCULATED OSTEOPOROSIS RISK ESTIMATION (SCORE) DOES NOT ALLOW IDENTIFICATION OF BELGIAN WOMEN WITH A HIGH RISK OF OSTEOPOROSIS
|
BenSedrine, W
|
|
2000
|
3 |
Supplement 1 |
p. 94-95
2 p.
|
artikel
|
| 45 |
Predictors of Long-term Persistence on Statins in a Subsidized Clinical Population
|
Catalan, Vanessa S
|
|
2000
|
3 |
Supplement 1 |
p. 417-426
10 p.
|
artikel
|
| 46 |
PRN7: RELIABILITY OF REPORTING ON COPING STRATEGIES AND IMPACT OF OVERACTIVE BLADDER
|
Stewart, WF
|
|
2000
|
3 |
Supplement 1 |
p. 141-142
2 p.
|
artikel
|
| 47 |
PRS6: QUALITY OF LIFE AND TREATMENT SATISFACTION MEASUREMENT WITH ASTHMA PATIENTS: RESULTS FROM A COMPREHENSIVE LITERATURE REVIEW
|
Abetz, LN
|
|
2000
|
3 |
Supplement 1 |
p. 328-329
2 p.
|
artikel
|
| 48 |
PSG2: TEN-YEAR COSTS ASSOCIATED WITH PERIPHERAL ARTERIAL DISEASE-RELATED INPATIENT PROCEDURES IN THE DEPARTMENT OF DEFENSE
|
Zachry, WM
|
|
2000
|
3 |
Supplement 1 |
p. 147-
1 p.
|
artikel
|
| 49 |
PSG5: THE ECONOMIC IMPACT OF THE USE OF PERFLUORO-N-OCTANE DURING RETINAL DETACHMENT SURGERY
|
Venkataraman, KS
|
|
2000
|
3 |
Supplement 1 |
p. 148-
1 p.
|
artikel
|
| 50 |
Q3: HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN AFRICAN AMERICAN MEN WITH PROSTATE CANCER: DATA FROM CaPSURE
|
Lubeck, DP
|
|
2000
|
3 |
Supplement 1 |
p. 54-
1 p.
|
artikel
|
| 51 |
Second Line Pharmacological Management of Paroxysmal and Persistent Atrial Fibrillation in France: A Cost Analysis
|
Moeremans, Karen
|
|
2000
|
3 |
Supplement 1 |
p. 407-416
10 p.
|
artikel
|
Tijdschrift beschrijving